GovChime
Notice ID: 90af33d4f1a043549bda132e0b612224Solicitation

MentorcliQ (Brand Name or Equal)

Archived on January 27, 2022. Original response deadline: . Full description on SAM.gov.

Overview

Response deadline
4:00 PM UTC−05:00
Posted
January 5, 2022
Notice type
Solicitation
Agency
Department of Health and Human ServicesFOOD AND DRUG ADMINISTRATION

Notice details

Office
FDA OFFICE OF ACQ GRANT SVCS
Last updated
Dec 4, 2025

Identifiers

Solicitation number
FDA-RFQ-22-1249591
Notice ID
90af33d4f1a043549bda132e0b612224

Description

The primary objective is to procure a cloud based mentoring platform that can accommodate up to 15,000 users, maintenance support, and training on a firm fixed price bases, for the MentorcliQ platform, brand name or equal. This is a combined/synopsis solicitation issued under FAR Part 12 and 13.5 procedures. This is an unrestricted procurement. The NAICS code is 541519. Quoters shall certify their quotes to be valid for at least 30 days. Quoters shall submit a quote for all requirements listed in this RFQ. Partial quotes will not be considered. Incomplete pricing or pricing with omissions may not be considered for award. Quoters shall submit all assumptions in their quotation. Quoters are advised that additional terms and conditions submitted with their quotation that is in conflict of the terms and conditions of this solicitation may be deems as technically unacceptable and may not be considered for award. All additional terms and conditions must be submitted with its quotation. The quote shall contain sufficient information to allow the Government to determine whether the quote is meeting all the requirements in the SOW. Quoters providing quotations must clearly state the overall cost to the Government. Quoters shall ensure that their initial submission represents their best pricing and that all information is provided to determine technical acceptability. The Government will not research items to determine compatibility; all information regarding compatibility must be contained within the quotation. Equal To quotes must meet all the salient characteristics in order to be considered technically acceptable. Equal to quotes must submit a separate Technical Quote with a detailed point-by-point description of how the Equal To products meet all the salient characteristics of this SOW. Equal to Quotes shall be required to operate seamlessly with all requirements out lined in Section 2 of this solicitation. Simiply returning the solicitation may deem your quote to be non responsive. Regeratation of the requirements out lined in Section 2 may be deemed technically unacceptable. Quotes providing the brand name product are not required to submit separate Technical Quotes. Technical Quotes shall not contain pricing information. Equal To quotes shall include a breakdown of all costs associated with the integration of the proposed solution into FDA environment. These costs shall be incorporated in the overall cost to the Government. For equal to quotations, Quoters will submit Section 508 Product Accessibility Templates (PAT) in full text with their quotations. For more information regarding PATs see: https://www.hhs.gov/web/section-508/contracting/technology-products/product-accessiblity-template/ If Quoters fail to address this Section 508 PAT in their quotes, they may be deemed non-responsive and not considered for award. Please submit questions to Min Jie (Terry) Zeng via email at minjie.zeng@fda.hhs.gov by January 7, 2021, 4PM Eastern Time. Please submit quotes to Min Jie (Terry) Zeng via email at minjie.zeng@fda.hhs.gov by January 12, 2021, 4PM Eastern Time.

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Documents

No documents available.

Lifecycle

Solicitation:FDA-RFQ-22-1249591
  1. Solicitation

Award typically follows within 30–90 days after the response deadline. (estimate)

  1. SolicitationCurrentJan 5, 2022

    MentorcliQ (Brand Name or Equal)

    Notice 90af33d4f1a043549bda132e0b612224 on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline

Additional Details

Solicitation Number

FDA-RFQ-22-1249591

Archive Date

Jan 27, 2022

Office Address

Beltsville, MD, 20705